Cell Transplantation, The Regenerative Medicine Journal is an open access, peer reviewed journal that is published 12 times annually. Cell Transplantation is a multi-disciplinary forum for publication of articles on cell transplantation and its applications to human diseases. Articles focus on a myriad of topics including the physiological, medical, pre-clinical, tissue engineering, stem cell, and device-oriented aspects of the nervous, endocrine, cardiovascular, and endothelial systems, as well as genetically engineered cells. Cell Transplantation also reports on relevant technological advances, clinical studies, and regulatory considerations related to the implantation of cells into the body in order to provide complete coverage of the field.
This journal is a member of the Committee on Publication Ethics (COPE).
Cell Transplantation features:
Original Contributions: Peer-reviewed, high-quality research investigations that represent new and significant contributions to science.
Review Articles: Reviews of major areas in cellular transplantation. These may be of any length and are peer reviewed.
Brief Communications: Timely and brief peer-reviewed studies.
Letters to the Editor: Readers' comments on journal articles and other matters of interest to transplant researchers.
Announcements and News: Notices of upcoming meetings, conferences, seminars, and other events of interest to those in the field.
As of 15th February 2018 the article processing charge (APC) will change to $275 USD per page with no additional fees for color figures. The APC is based on the date of original submission so all articles submitted before 15th February 2018 will be subject to the original price (page charge + color figure fee) regardless of the article's date of acceptance.
For articles submitted before 15th February 2018, the following APC still applies: Please note that publication charges are determined by the number of pages. The current rate is $1,100 for 1-4 pages; $2,200 for 5-12 pages; + $100/page for each additional page. Color figures are subject to an additional fee, outlined in the manuscript guidelines. An invoice will be sent to the author at the proof stage and payment is required before publication.
Each article accepted after peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity.
Submit your manuscript today at https://mc.manuscriptcentral.com/celltransplantation
Please direct any enquiries to email@example.com.
Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances and ethical and regulatory considerations of cell transplants. Cell Transplantation has been free to read since 2009.
|Paul R. Sanberg||University of South Florida Morsani College of Medicine, USA|
|Shinn-Zong Lin||Tzu Chi University, Taiwan|
|Section Editor: Amit Patel||University of Miami School of Medicine, USA|
|Piero Anversa||New York Medical College, USA|
|Enio Buffolo||Federal University of São Paulo, Brazil|
|Wangde Dai||University of Southern California, USA|
|Henricus D. Duckers||Erasmus University Medical Center, The Netherlands|
|Joshua Hare||University of Miami, USA|
|Nelson A. Hossne, Jr.||Federal University of São Paulo, Brazil|
|Jens Kastrup||University of Copenhagen, Denmark|
|Ren Ke Li||University of Toronto, Canada|
|Virginia M. Miller||Mayo Clinic College of Medicine, USA|
|Marc S. Penn||Summa Cardiovascular Institute, USA|
|Warren Sherman||Columbia University, USA|
|Christof Stamm||Deutches Herzzentrum Berlin, Germany|
|Section Editor: Stephen Strom||Karolinska Institute, Sweden|
|J. Roy Chowdhury||Albert Einstein College of Medicine, USA|
|Bruno Christ||Martin Luther University, Germany|
|Anil Dhawan||King's College Hospital, UK|
|Ewa Ellis||Karolinska Institute, Sweden|
|Ira Fox||University of Pittsburgh, USA|
|Mariá José Gómez-Lechón||Hospital La Fe, Spain|
|Toshihiro Mitaka||Sapporo Medical University, Japan|
|Andreas Nüssler||University of Tübingen, Germany|
|Kazuo Ohashi||Tokyo Women's Medical University, Japan|
|Michael Ott||Hannover Medical School, Germany|
|Paolo Parini||Karolinska Institute, Sweden|
|Etienne M. Sokal||Université Catholique de Louvain, Belgium|
|Donna Stolz||University of Pittsburgh, USA|
|Shuji Terai||Yamaguchi University, Japan|
|Section Editor: Rodolfo Alejandro||University of Miami School of Medicine, USA|
|Thierry Berney||Geneva University Hospital, Switzerland|
|Federico Bertuzzi||Ospedale Niguarda Cà Granda, Italy|
|Susan Bonner-Weir||Joslin Diabetes Center, USA|
|Luis Fernandez||H4/782 Clinical Science Center, USA|
|Alberto Hayek||The Whittier Institute, USA|
|Jose Oberholzer||University of Illinois at Chicago, USA|
|Klearchos K. Papas||University of Arizona, USA|
|Lorenzo Piemonti||San Raffaele Scientific Institute, Italy|
|Michael R. Rickels||University of Pennsylvania, USA|
|Peter Senior||Alberta Diabetes Institute, Edmonton, Canada|
|Charmaine J. Simeonovic||Australian National University, Australia|
|Stacey Walters||Garvan Institute of Medical Research, Australia|
|Yong Wang||University of Illinois at Chicago, USA|
|Gordon C. Weir||Joslin Diabetes Center, USA|
|Section Editor: Dragos Cretoiu||Carol Davila University of Medicine and Pharmacy, Romania|
|Reinhard Bretzel||Justus-Liebig University, Germany|
|Wei-Ming Duan||Ohio University, USA|
|Luca Falqui||San Raffaele Scientific Institute, Italy|
|Craig R. Halberstadt||Tengion, Inc., USA|
|Luca Inverardi||University of Miami School of Medicine, USA|
|Roger James||University of Leicester, UK|
|Norma Sue Kenyon||University of Miami School of Medicine, USA|
|Jonathan Lakey||University of California Irvine, USA|
|Walter Low||University of Minnesota, USA|
|Hyeyoung Moon||Korea Basic Science Institute, Korea|
|Waldemar L. Olszewski||Polish Academy of Sciences, Poland|
|Gary Peltz||Stanford University School of Medicine, USA|
|Artur Pasternak||Jagiellonian University Medical College, Poland|
|Evan Y. Snyder||Burnham Institute for Medical Research, USA|
|Junjie Xiao||Shanghai University, China|
|Section Editor: Jacques P. Tremblay||CHUL, Canada|
|Johnny Huard||Steadman Philippon Research Institute, USA|
|Stanislaw Moskalewski||Medical School of Warsaw, Poland|
|Terence A. Partridge||Children's National Medical Center, USA|
|A. Hari Reddi||University of California, Davis, USA|
|Myron Spector||VA Boston Healthcare System, USA|
|Jean-Thomas Vilquin||INSERM, France|
|Section Editor: Marina Emborg||University of Wisconsin, USA|
|Section Editor: Pavla Jendelova||Charles University, Czech Republic|
|Section Editor: John R. Sladek||University of Colorado, USA|
|Elisabet Åkesson||Karolinska Institute, Sweden|
|Ernest Arenas||Karolinska Institute, Sweden|
|Johannes Boltze||Fraunhofer Institute for Cell Therapy and Immunology, Germany|
|Michael Chopp||Henry Ford Hospital, USA|
|Isao Date||Okayama University, Japan|
|Gary Dunbar||Central Michigan University, USA|
|John Elsworth||Yale University, USA|
|David Eve||University of South Florida, USA|
|Thomas B. Freeman||University of South Florida, USA|
|Monte A. Gates||University of Keele, UK|
|David C. Hess||Medical College of Georgia, USA|
|Hideki Hida||Nagoya City University, Japan|
|Stuart I. Hodgetts||University of Western Australia, Australia|
|Hongyun Huang||Beijing Hongtianji Neuroscience Academy, China|
|Kyung-Sun Kang||Seoul National University, Korea|
|Emma Lane||Cardiff University, UK|
|Robert S. Langer||Massachusetts Institute of Technology, USA|
|Agnes Luo||Case Western Reserve University, USA|
|Antonios G. Mikos||Rice University, USA|
|Robert M. Nerem||Georgia Institute of Technology, USA|
|Guido Nikkhah||Albert-Ludwigs-University, Germany|
|Giles Plant||Stanford University School of Medicine, USA|
|Michael Sefton||University of Toronto, Canada|
|Ashok Shetty||Texas A&M Health Science Center, USA|
|Jihwan Song||CHA University, Korea|
|Yun Wang||National Institute on Drug Abuse, NIH, USA|
|John A. Watt||University of North Dakota, USA|
|Hans Widmer||Bern University Hospital, Switzerland|
|Takao Yasuhara||Okayama University, Japan|
|Section Editor: Maria Carolina Oliveira Rodrigues||University of São Paulo, Brazil|
|Kerry Atkinson||Mater Medical Research Institute, Australia|
|Hal E. Broxmeyer||Indiana University, USA|
|Francesca Cicchetti||CHUL, Canada|
|Curt I. Civin||Johns Hopkins University, USA|
|Mari Dezawa||Tohoku University, Japan|
|Antonio Ibarra||Universidad Anáhuac México Norte, Mexico|
|Kyu-Shik Jeong||Kyungpook National University, Korea|
|Helen Kaipe||Karolinska Institutet, Sweden|
|Giampiero La Rocca||University of Palermo, Italy|
|Oscar K. Lee||National Yang-Ming University, Taiwan|
|Daniela Moraes||University of São Paulo, Brazil|
|Ching-Tien Peng||China Medical University, Taiwan|
|Mariusz Ratajczak||University of Louisville, USA|
|Bernat Soria||Catedratico Extraordinario de Medicina Regenerativa, Spain|
|Gerald J. Spangrude||University of Utah, USA|
|John E. Wagner||University of Minnesota, USA|
|Susanne Wolbank||Ludwig Boltzmann Institute, Austria|
|Khang-Hsi Wu||China Medical University, Taiwan|
|Li-Ru Zhao||SUNY Upstate Medical University, USA|
|Section Editor: Shinn-Zong Lin||Hualien Tzu Chi Hospital, Taiwan|
|Koji Abe||Okayama University, Japan|
|Mitchell S. Cairo||New York Medical College, USA|
|Fu-Chou Cheng||Taichung Veterans General Hospital, Taiwan|
|Tzyy-Wen Chiou||National Dong Hwa University, Taiwan|
|Der-Yang Cho||China Medical University Hospital, Taiwan|
|Ru-Huei Fu||China Medical University Hospital, Taiwan|
|Xiaosong Gu||Nantong University, China|
|Horng-Jyh Harn||Hualien Tzu Chi Hospital, Taiwan|
|Niranjan Khandelwal||Postgraduate Institute of Medical Education and Research, India|
|Ching Ann Liu||Buddhist Tzu Chi Medical Foundation|
|Shih-Ping Liu||China Medical University, Taiwan|
|Shinichi Matsumoto||Baylor Research Institute, USA|
|Michel Modo||University of Pittsburgh, USA|
|Greg Nowak||Karolinska Institute, Sweden|
|Dario Siniscalco||Second University of Naples, Italy|
|Kwok-Fai So||University of Hong Kong, Hong Kong|
|Hong-Lin Su||National Chung Hsing University, Taiwan|
|Xiao-Ming Xu||Indiana University, USA|
|Wise Young||Rutgers State University of New Jersey, USA|
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to
Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site
https://mc.manuscriptcentral.com/celltransplantation to upload your manuscript. Please note that
manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of Cell Transplantation will be
As part of the submission process you will be required to warrant that you are submitting your original
work, that you have the rights in the work, that you are submitting the work for first publication in the
Journal and that it is not being considered for publication elsewhere and has not already been published
elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of
any copyright works not owned by you.
Please include a cover letter, containing the name, full mailing address, telephone, email address and
fax number (if applicable) of the author responsible for correspondence. Follow the Preparing Your
Manuscript (section 6) guidelines below to prepare the manuscript, figures, and tables.
Please read the Manuscript Submission Guidelines below before submitting your manuscript here:
- Open Access
- Article processing charge (APC)
- What do we publish?
3.1 Aims & scope
3.2 Article types
3.3 Writing your paper
3.3.1 Making your article discoverable
- Editorial policies
4.1 Peer Review Policy
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.6.1 Use of Animal- and Human- derived tissue
4.7 Clinical Trials
4.8 Reporting guidelines
- Publishing policies
5.1 Publication ethics
5.1.2 Previous publication
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Word processing formats
6.2 Artwork, figures and other graphics
6.3 Supplementary material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 How to submit your manuscript
7.2 Title, keywords and abstracts
7.3 Information required for completing your submission
7.3.1 Corresponding author contact details
- On acceptance and publication
8.1 SAGE Production
8.2 Continuous publication
8.3 Promoting your article
- Further information
Cell Transplantation is an open access, peer-reviewed journal. Each article accepted by peer review is
made freely available online immediately upon publication, is published under a Creative Commons
license and will be hosted online in perpetuity. Publication costs of the journal are covered by the
collection of article processing charges which are paid by the funder, institution or author of each
manuscript upon acceptance. There is no charge for submitting a paper to the journal.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
(APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
available online in perpetuity under a Creative Commons license.
[Price change, see underlined below.] At the time of submission you will be asked to confirm that you
will pay the open access fees. The page charge fee is based on the page count estimate made after
acceptance ($1,100 for less than 5 pages, $2,200 for 5-12 pages and +$100 for each additional page)
[Price change, see underlined below.] Additional color charges for figures/illustrations may apply. Color
charges are $895 for 1 figure; $1,250 for 2 figures; $1,575 for 3 figures; and $2,050 for 4+ figures.
As of 15th February 2018 the article processing charge (APC) will change to $275 USD per page with no
additional fees for color figures. The APC is based on the date of original submission so all articles
submitted before 15th February 2018 will be subject to the original price (page charge + color figure fee)
regardless of the article's date of acceptance. If you have any questions please contact the Editorial
Office at firstname.lastname@example.org. The APC is payable upon acceptance after peer review and
subject to VAT where applicable.
The contributing author will be sent a pro forma invoice detailing charges and will be given an
opportunity to confirm payment details and other information. Following confirmation, the actual
invoice will be issued to the contributing author.
Before submitting your manuscript to Cell Transplantation, please ensure you have read the Aims & Scope.
On the first page should be the abstract (a maximum of 300 words) and 4-6 keywords. All
tables should be placed at the end of the file and numbered in the order they appear in the
text. We strongly encourage the appropriate use of bar charts and line graphs to illustrate key
findings. Figures should be placed in individual files (we accept TIFF, JPEG, and eps), separate
from the main document file.
Article types published by Cell Transplantation are given below; certain article types
observe limits on words and in-text tables. Please see below. Word limits include tables,
but not abstracts, key words, or references.
- Original Research– Peer-reviewed, high-quality research investigations that represent
new and significant contributions to science.
- Reviews– Reviews of major areas in cellular transplantation. These may be of any length,
may include figures (schematics) and are peer reviewed.
- Brief Communications – Timely and brief peer-reviewed studies.
- Maximum of two tables or two figures (or one table and one figure). Maximum
page limit is 5 pages once typeset, not including the reference list.
- Maximum of two tables or two figures (or one table and one figure). Maximum
- Case Studies
- Editorials/Letters to the Editor– Editor’s opinion or insight on a topic/ Readers'
comments on journal articles and other matters of interest to transplant researchers.
- Announcements and News – Notices of upcoming meetings, conferences,
seminars, and other events of interest to those in the field.
- Commentary– May be for responses to published papers, responses to other comments,
opinion pieces on new or old important topics in the field, etc.
Editorials and Commentaries will not be charged an APC.
All article types require a structured abstract except commentaries, which include a summary.
Cell Transplantation uses the Council of Science Editors (citation-sequence) style for formatting
citations and the reference list.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
When writing up your paper, think about how you can make it discoverable. The title,
keywords and abstract are key to ensuring readers find your article through search
engines such as Google. For information and guidance on how best to title your article,
write your abstract and select your keywords, have a look at this page on the Gateway:
How to Help Readers Find Your Article Online.
Following a preliminary triage to eliminate submissions unsuitable for Cell Transplantation, all
papers are sent out for review.
The journal’s policy is to have manuscripts reviewed by two expert reviewers. Cell
Transplantation utilizes a single- blind peer review process in which the reviewer’s names and
information is withheld from the author.
Reviewers are expected to not possess any conflicts of interest with the authors and research.
They should review the science objectively and provide recommendations for improvements
where necessary. When aware of relevant published work not being cited, the reviewers should
recommend inclusion of these references. If the reviewer feels that they would be unable to
repeat the study as described, then additional methodological details should be requested. Any
unpublished information read by a reviewer should be treated as confidential.
All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Peer review is
managed by the Cell Transplantation Editorial Office Peer who assigns each submitted
manuscript to appropriate reviewers and, with the input of the Editorial Board, and comments
and recommendations of the reviewers, makes decisions on the eligibility of the article for
Papers should only be submitted for consideration once consent is given by all contributing
authors. Those submitting papers should carefully check that all those whose work contributed
to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all
(i) Made a substantial contribution to the concept or design of the work; or acquisition,
analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public
responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have
participated sufficiently in the work to take public responsibility for appropriate portions of the
When a large, multicentre group has conducted the work, the group should identify the
individuals who accept direct responsibility for the manuscript. These individuals should fully
meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone
does not constitute authorship, although all contributors who do not meet the criteria for
authorship should be listed in the Acknowledgments section. Please refer to the International
Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on
The reported research must be novel and authentic and the authors should confirm that the
same data has not been and is not going to be submitted to another journal (unless already
rejected). Statements made in the introduction and discussion should be supported by
appropriate references and sufficient experimental detail should be provided to allow for
repetition of the study by another group. Plagiarism of the text/data will not be tolerated and
could result in retraction of an accepted article. Any text or figures reproduced for another
source require the permission of the original copyright holders (normally the publishers).
Any manipulation of figures should be equally applied and described in the text including
pseudo-coloring and must not change the meaning of the figure.
When humans, animals or tissue derived from them have been used, then mention of the
appropriate ethical approval must be included in the manuscript.
All contributors who do not meet the criteria for authorship should be listed in an
Acknowledgements section. Examples of those who might be acknowledged include a person
who provided purely technical help, or a department chair who provided only general support.
Financial support and conflicts of interest for all authors must be declared. Further information
on this can be obtained from the International Committee for Medical Journal Editors
Please acknowledge any funding support. In addition, all authors need to disclose any conflicts
of interest, financial or otherwise, in a separate section before the references. Conflicts of
interest may include:
1. Direct ownership of equity or shares in a health care or pharmaceutical company
relating to the manuscript, by any author or their immediate family members.
2. Receipt of any form of income by any author or their immediate family members from
health care or pharmaceutical companies related to the manuscript within the calendar
year preceding original submission.
3. Personal interest such as being an expert witness, public advocate, grantee, consultant,
founder, owner, or employee of a health care or pharmaceutical company related to the
4.3.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do
not qualify as authors and so should be included in the Acknowledgements section. Authors
must disclose any writing assistance – including the individual’s name, company and level of
input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of
Conflicting Interests (if applicable), any notes and your References.
Cell Transplantation requires all authors to acknowledge their funding in a consistent fashion
under a separate heading. Please visit the Funding Acknowledgements page on the SAGE
Journal Author Gateway to confirm the format of the acknowledgment text in the event of
funding, or state that: This research received no specific grant from any funding agency in the
public, commercial, or not-for-profit sectors.
It is the policy of Cell Transplantation to require a declaration of conflicting interests from all
authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of
your manuscript, after any acknowledgements and prior to the references. If no conflict exists,
please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
In addition, there are sections for detailing any conflicts of interest and financial support and
that you (as corresponding/submitting author) have the permission of the other authors to
submit the manuscript.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the World Medical
Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
All papers reporting animal and/or human studies must state in both the Methods section and in
the ethical statements (following the Conclusion, before the References) that the relevant Ethics
Committee, Institutional Review Board (IRB), or Institutional Animal Care and Use Committee
(IACUC) provided (or waived) approval. Please ensure that you have provided the full name and
institution of the review committee, in addition to the approval number.
- Please address the following statements. Please refer to the sample statements in this
template (Word doc) to help you decide which statement is applicable for your work.
Include these at the end of your manuscript directly in the document.
- Ethical Approval
- Statement of Human and Animal Rights
- Statement of Informed Consent
- For research articles, case reports, and other relevant articles, authors
are required to state whether participants provided informed consent
for patients information and images to be published and whether the
consent was written or verbal or provided by a legally authorized
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
Please confirm within the text that the appropriate ethical and/or regulatory body approved the
use of animal- or human-derived tissue (as well as informed consent for humans). With human
derived data, articles are published on the understanding that appropriate measures to protect
the privacy of the individuals were undertaken.
Cell Transplantation conforms to the ICMJE requirement that clinical trials are registered in a
WHO-approved public trials registry at or before the time of first patient enrolment as a
condition of consideration for publication. The trial registry name and URL, and registration
number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type
of study. For example, all randomized controlled trials submitted for publication should include
a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
should include the completed PRISMA flow chart as a cited figure and the completed
PRISMA checklist should be uploaded with your submission as a supplementary file. The
EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to
refer to the Committee on Publication Ethics’ International Standards for Authors and view the
Publication Ethics page on the SAGE Author Gateway.
Cell Transplantation and SAGE take issues of copyright infringement, plagiarism or other
breaches of best practice in publication very seriously. We seek to protect the rights of our
authors and we always investigate claims of plagiarism or misuse of published articles. Equally,
we seek to protect the reputation of the journal against malpractice. Submitted articles may be
checked with duplication-checking software. Where an article, for example, is found to have
plagiarized other work or included third-party copyright material without permission or with
insufficient acknowledgement, or where the authorship of the article is contested, we reserve
the right to take action including, but not limited to: publishing an erratum or corrigendum
(correction); retracting the article; taking up the matter with the head of department or dean of
the author's institution and/or relevant academic bodies or societies; or taking appropriate legal
If material has been previously published, it is not generally acceptable for publication in a SAGE
journal. However, there are certain circumstances where previously published material can be
considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in
doubt, contact the Editor at the address given below.
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
Publishing Agreement. Cell Transplantation publishes manuscripts under Creative Commons
licenses. The standard license for the journal is Creative Commons by Attribution NonCommercial
(CC BY-NC), which allows others to re-use the work without permission as long as
the work is properly referenced and the use is non-commercial. For more information, you are
advised to visit SAGE's OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder
mandates, made at the author’s request.
Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. Papers
should be typed in English, double-spaced throughout with at least 3-cm margins on paper
approximately 22 ´ 28 cm (8 1/2 ´ 11 in.) in size. Please consult the most recent issue of the
journal for style and format. Number all pages consecutively, beginning with the title page. Use
metric units of measure; other units may be given in parentheses. Typically, only three levels of
headings are recognized. The paper should be organized as follows.
Title Page: The title should be brief and specific. The title page should contain, in the following
order: title, name(s) and affiliation(s) of author(s) including city, state, postal code, and country,
and a suggested running head of not more than 50 characters and spaces. Also indicate which
author will be the corresponding author (i.e., to whom correspondence should be addressed,
with complete mailing address, telephone and fax numbers, and e-mail necessary for sending
proofs). In general, no more than two shared first and/or senior authorships can be considered
and they must be appropriately justified in the letter to the editor at the time of submission. The
rule can be reassessed on a case-by-case basis for manuscripts arising from multicenter
collaborations, but please note that the production office will not liaise with more than two
corresponding authors. In the case of two corresponding authors, the proof will only be sent to
the first mentioned corresponding author.
Abstract: An abstract of 300 words or less should begin on page 2. It should contain a concise
summary of the results, conclusions, and other significant points in the review.
Key words: For the purpose of subject indexing, provide four to six keywords immediately
following the abstract.
Text: Every effort should be made to avoid jargon, to spell out all nonstandard abbreviations the
first time they are used, and to present the contents of the study as clearly and concisely as
possible. In the Materials and Methods section, authors are required to supply sufficient detail
for replication of the study, including the name of the company from which the materials
(reagents and equipment) were supplied and the location of company headquarters (city, state
if in the U.S., and country). References to previously described methods must be properly cited
and also described in moderate detail. References should be given for all discussions and
conclusions of previous studies. Trade names may appear in parentheses and should be
capitalized. Critical discussions of the literature are preferred more than historically oriented
Tables: All tables must be created in Microsoft Word. Tables should be numbered and cited
sequentially in the text. Prepare each table as a separate page at the end of the manuscript text,
after the references. Avoid very wide or long tables that would not fit a printed page. Each table
should have a title, and each column in the table should have a brief heading. Define all
abbreviations in the table footnote at the bottom of the table.
Figures: Figures should be numbered and cited sequentially in the text. Each figure should be
provided as a separate file (see Final Accepted Manuscript). Include all parts of a figure (e.g., A,
B, etc.) as one file. Do not use light lettering and shading that will not reproduce well. Figure
dimensions and scaling should be suitable for reduction (if necessary) to fit column or page size.
Care must be taken that letters and other symbols do not become so small that they are illegible
when the figure is reduced. Complex formulas should be prepared as illustrations. (Do not
embed figures within the manuscript text.) The author is required to bear the costs for the
publication of color figures (costs and color authorization form will be provided at proof stage).
Authors may submit a color photograph for consideration as a cover photo for the issue in which
their article appears.
Figure Legends: Each figure legend must have a short title that concisely describes the content
of each figure. List all figure legends sequentially on one or more pages at the end of the
manuscript text, after the references, and identify all symbols used in the figures. The figure
legend should be as clear as possible and should fully describe the contents of the figure. (Do
not include the figure legend as part of the figure). If the figure is from a previously published
article, indicate that permission has been obtained from the original publisher.
Figure Files: Each figure should be provided as a separate, high-resolution file. Simple black and
white figures (e.g., line graphs, bar graphs, etc.) should be 1200 dpi. Halftone and color figures
(or combo figures) should be 600 dpi. Final figure files should be submitted as tiff, jpg, or eps
format. Do not include the figure number as part of the figure file (e.g., do not label Figure 1,
etc., as part of the figure). Do not provide color in a figure file unless the figure will be printed in
color (note there is a cost for printing figures in color).
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
etc) alongside the full-text of the article. These will be subjected to peer-review alongside the
article. For more information please refer to our guidelines on submitting supplementary files,
which can be found within our Manuscript Submission Guidelines page.
Literature cited should be prepared according to the Council of Science Editors format (citationsequence)
style. This format is conveniently in Endnote and the output style is available at the
Some examples are provided below. References in the text should be cited by superscript number separated by a comma and listed in numerical order as they appear in the text (double
spaced) on a separate page at the end of the manuscript. Journal citations in the reference list
should contain the following: (a) reference number NOT in superscript; (b) surnames and initials
of all authors (surnames precede initials); (c) title of article; (d) journal title abbreviated as listed
in ISSN.org; (e) year; volume, inclusive pages. See the examples shown and refer to Council of
Science Editors format for more examples.
Journal Article: Wang Y, Nathanson L, McNiece IK. Differential hematopoietic supportive
potential and gene expression of stroma cell lines from midgestation mouse placenta and adult
bone marrow. Cell Transplant. 2011;20:707–26.
Book Article/Chapter: Taylor MJ, Baicu, S. Hypothermic perfusion of pancreas: Emphasis on
preservation prior to islet isolation. In: Uygun K, Lee CY, editors. Organ preservation and
reengineering. Boston (MA): Artech House Publisher; 2011. p. 85-104.
Book: Wang-Fischer Y. Manual of stroke models in rats, 1st ed. Boca Raton (FL): CRC Press; 2009.
Internet Source: Stem Cell Research Oversight Committee. University of Wisconsin-Madison
policy for multisite research studies using human pluripotent stem cells [Internet]. Madison
(WI): University of Wisconsin-Madison; 2009 [cited 2013 Sep 12]. Available from
An example of an in-text citation is shown below.
Traumatic life events and posttraumatic stress disorder (PTSD) are endemic among American
To cite multiple sources, all numbers associated with the reference being cited should be
superscript, separated by a comma, with no spaces between them.
Statistics: If statistical analysis was performed, define the tests used in the methods and ensure
that it is clear what comparisons are made. Please ensure that appropriate testing was
performed when multiple comparisons (i.e., one group compared to more than one other
group) were made.
Manuscripts should be grammatically correct and completely comprehendible upon submission
before they will be forwarded for peer review.
Authors seeking assistance with English language editing, translation, or figure and manuscript
formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit
SAGE Language Services on our Journal Author Gateway for further information.
Cell Transplantation is hosted on SAGE Track, a web based online submission and peer review
system powered by ScholarOne™ Manuscripts. Visit
https://mc.manuscriptcentral.com/celltransplantation to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to
create a new one. If you have reviewed or authored for the journal in the past year it is likely
that you will have had an account created. For further guidance on submitting your manuscript
online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. The title,
keywords and abstract are key to ensuring readers find your article online through online search
engines such as Google. Please refer to the information and guidance on how best to title your
article, write your abstract and select your keywords by visiting the SAGE Journal Author
Gateway for guidelines on How to Help Readers Find Your Article Online.
Provide full contact details for the corresponding author including email, mailing address and
telephone numbers. Academic affiliations are required for all co-authors. These details should
be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the
submission system and identify who is to be the corresponding author. These details must
match what appears on your manuscript. At this stage please ensure you have included all the
required statements and declarations and uploaded any additional supplementary files
(including reporting guidelines where relevant).
Provide full contact details for the corresponding author including email, mailing address and
telephone numbers. Academic affiliations are required for all co-authors. These details should
be presented separately to the main text of the article to facilitate anonymous peer review.
As part of our commitment to ensuring an ethical, transparent and fair peer review process
SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID
provides a persistent digital identifier that distinguishes researchers from every other researcher
and, through integration in key research workflows such as manuscript and grant submission,
supports automated linkages between researchers and their professional activities ensuring that
their work is recognized.
We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their
ORCIDs as part of the submission process. If you don’t already have one you can create one
Authors are responsible for obtaining permission from copyright holders for reproducing any
illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
information including guidance on fair dealing for criticism and review, please visit our
Frequently Asked Questions on the SAGE Journal Author Gateway.
If your paper is accepted for publication after peer review, you will first be asked to complete the
contributor’s publishing agreement. All material accepted for publication is subject to copyediting.
Authors will receive page proofs of articles before publication, along with an APC authorization form
(with the final cost based on the number of printed pages) and Color Figure authorization form (if there
are potential color figures), which will need to be completed and returned before the article can be
processed for publication. Note that if the figures were originally in color but you decide not to print in
color at proof stage the text/legends may need to be modified to reflect this change. Please note that if
the lack of color makes the figure difficult to interpret then revised figures (or agreement to pay for
color) may be required.
When your paper enters the SAGE Production system, your paper will be issued with a 6 digit ID
number. Your SAGE Production Editor will keep you informed as to your article’s progress
throughout the production process. Proofs will be sent by PDF to the corresponding author and
should be returned promptly. Authors are reminded to check their proofs carefully to confirm
that all author information, including names, affiliations, sequence and contact details are
correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note
that if there are any changes to the author list at this stage all authors will be required to
complete and sign a form authorizing the change.
One of the many benefits of publishing your research in an open access journal is the speed to
publication. With no page count constraints, your article will be published online in a fully
citable form with a DOI number as soon as it has completed the production process. At this time
it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is
as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help
you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich,
share, and measure the impact of their article. Find out how to maximize your article’s impact
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Managing Editor, Samantha Portis at email@example.com. Tel: 813 974 4691.